Connectez-vous pour accéder aux recommandations de stratégie gagnante.
Se connecterPassez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.
Se connecter15 exigences dans 5 catégories
Inscrivez-vous pour consulter les exigences et l'analyse complètes
8 documents disponibles avec des résumés IA
This document outlines the compliance conditions for the procurement of alpha-galactosidase and beta-galactosidase medicines, requiring bidders to submit an application, power of attorney (if applicable), a declaration against sanctions, and the technical specification and price offer form.
This document is a price offer form requiring bidders to submit technical specifications and unit prices for alfaagalsidase and betaagalsidase drugs for a two-year period, including fields for bidder information.
This form is an application for tender submission, requiring bidder details and confirmations of compliance with tender conditions and qualification criteria.
This document outlines the evaluation criteria and methodology for the procurement of alfaagalsidase and betaagalsidase medicines, where the sole evaluation criterion is the lowest total cost (with a 100% weighting).
This document serves as an explanatory guide for the European Single Procurement Document (ESPD), detailing the contracting authority's qualification requirements and exclusion grounds that bidders must declare electronically.
This document outlines the open procurement procedure for the purchase of alpha-galactosidase (A16AB03) and beta-galactosidase (A16AB04) medicines, detailing the general terms of the tender.
This document is a draft framework agreement outlining the terms and legal framework for the procurement of alpha-galactosidase and beta-galactosidase drugs.
This document contains required tender submission forms, including a power of attorney for signing the tender and an application for participation in the procurement procedure with bidder details.
Inscrivez-vous pour consulter les résumés et l'analyse des documents
This tender for specific pharmaceutical products demonstrates good clarity and fairness, leveraging e-procurement effectively. However, it presents a notable inconsistency regarding evaluation criteria and lacks explicit sustainability considerations.
The tender adheres to legal requirements with reasonable deadlines (35 days), appropriate CPV codes, and no detected disputes. The use of ESPD and an open procedure aligns with national regulations. The generic procedure type code is a minor point.
While the overall description and requirements are well-documented and understandable, there is a significant inconsistency regarding the evaluation criteria. The basic information states 'relative_weighting,' but the dedicated document specifies 'lowest total cost (100% weighting),' which can cause confusion for bidders.
The tender is largely complete, providing all basic information, estimated value, and clear deadlines. The duration of the framework agreement until 31.03.2028 is specified in the description, and all necessary documents and forms are attached.
This tender scores highly on fairness, offering full document access, disclosing the estimated value, and providing reasonable deadlines for preparation. The use of e-procurement and objective 'lowest total cost' evaluation criteria ensures equal access and transparency. Requirements appear generic for the product type and not tailored.
The tender is practical, supporting electronic submission and e-procurement. The opening place URL is provided, and the duration of the framework agreement is clear. The absence of an explicit contract start date is a minor detail.
Key fields are populated, and dates are logical. However, the inconsistency between the stated 'relative_weighting' evaluation criteria in the basic characteristics and the 'lowest total cost (100% weighting)' in the evaluation document is a notable data inconsistency. The 'Value Classified: Yes' while the value is disclosed is also a minor inconsistency.
The tender does not explicitly include green procurement, social aspects, or innovation focus. While common for specific medical supplies, this represents a missed opportunity to integrate broader sustainability considerations into the procurement process.
Inscrivez-vous pour consulter les exigences et l'analyse complètes
Aucune carte de crédit requise • Configuration en 2 minutes
Bonjour ! Je suis votre assistant IA pour cet appel d'offres. Je peux vous aider à comprendre les exigences, les délais, les critères d'admissibilité et vous fournir des informations stratégiques.
Aucune carte de crédit requise